Event Session
Biopharma Law & Policy Update: Legislation, Executive Action and Industry Impact *
October 27, 2025 @ 10:30 AM EST
10:30 AM ET
October 27, 2025
Biopharma Law & Policy Update: Legislation, Executive Action and Industry Impact *
The biopharmaceutical industry sits at the intersection of rapid scientific advancement and an increasingly complex legal and regulatory environment. This panel will dig into the latest developments in U.S. legislation, executive actions, and regulatory initiatives shaping the future of drug development, commercialization, and protection. Panelists will analyze how recent and pending actions in Congress and the White House could reshape innovation incentives, market exclusivity, pricing, and competition. Attendees will gain actionable insights into how companies can adapt to shifting legal frameworks, anticipate policy changes, and navigate a landscape where political priorities and industry realities often collide.
Materials:
Peter-Anthony Pappas for Senator Tillis at FTC-DOJ Listening Session on Lowering Drug Prices
Patent Eligibility Reform Returns to the Hill: PERA 2025 Explained
PERA 2025 Debated in Senate IP Subcommittee Hearing, with Business Methods, Diagnostics in Focus
Senate Judiciary Committee to Consider Bills Targeting Pharma Patents and Pricing
Latest Trump Executive Order Redirects Drug Pricing Debate
SURVEY:
https://www.surveymonkey.com/r/Biopharma-Law-and-Policy-Update
The biopharmaceutical industry sits at the intersection of rapid scientific advancement and an increasingly complex legal and regulatory environment. This panel will dig into the latest developments in U.S. legislation, executive actions, and regulatory initiatives shaping the future of drug development, commercialization, and protection. Panelists will analyze how recent and pending actions in Congress and the White House could reshape…
Session Speakers
Sponsors
